Nasdaq published this video item, entitled “Behind the Bell: Lexeo Therapeutics” – below is their description.
In this episode of Behind the Bell, CEO of Lexeo Therapeutics R. Nolan Townsend, shares what it means to be Nasdaq listed and the impact on the company’s mission in genetic medicine to treat a broad range of diseases, such as cardiovascular and Alzheimer’s diseases.
Watch more of Behind the Bell on Nasdaq.com: https://www.nasdaq.com/news-and-insights/behind-the-bell
Nasdaq YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.